Assessing Change in Cognitive Function in Dementia: The Relative Utilities of the Alzheimer’s Disease Assessment Scale – Cognitive Subscale and the Cognitive Drug Research System

Publisher： Karger

E-ISSN： 1660-2862|5|3-4|261-263

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.3-4, 2008-03, pp. : 261-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tracking Cognitive Change over 24 Weeks with Longitudinal Functional Magnetic Resonance Imaging in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 4, 2012-03 ,pp. : 176-186

Karger

Access to resources Recommend Favorite

Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 241-243

Karger

Access to resources Recommend Favorite

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-08 ,pp. : 157-159

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 251-259

Karger

Access to resources Recommend Favorite